LncRNA SNORD3A specifically sensitizes breast cancer cells to 5-FU by sponging miR-185-5p to enhance UMPS expression
Open Access
- 7 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 11 (5), 1-12
- https://doi.org/10.1038/s41419-020-2557-2
Abstract
Breast cancer is the most common cancer type in women. Long non-coding RNAs (lncRNAs) have been reported as potential new diagnostic markers, prognostic factors, and therapeutic targets in cancer. However, the specific roles and mechanisms of lncRNAs in breast cancer remain to be elucidated. Here we demonstrated the downregulation of lncRNA SNORD3A in breast cancer cells and tissues and verified its non-protein-coding property. SNORD3A overexpression had no effect on cell proliferation but specifically sensitized breast cancer cells to 5-fluorouracil (5-FU) in vitro and in vivo. Mechanistically, SNORD3A exerts its effect via enhancing uridine monophosphate synthetase (UMPS) protein expression. SNORD3A acts as a competing endogenous RNA for miR-185-5p, leading to UMPS protein upregulation. miR-185-5p overexpression disrupted the effect of SNORD3A on chemosensitization to 5-FU in vitro and in vivo. Moreover, Meis1 overexpression transcriptionally promotes SNORD3A expression, and Meis1 is downregulated in breast cancer cells and tissues. In breast cancer tissues, SNORD3A level positively correlates with Meis1 and UMPS protein levels, whereas miR-185-5p level negatively correlates with UMPS protein level. High SNORD3A transcript and Meis1 and UMPS protein levels predicts a better outcome, but high miR-185-5p level predicts a worse outcome in breast cancer patients receiving 5-FU-based chemotherapy. Our findings indicate that Meis1-regulated SNORD3A specifically sensitizes breast cancer cells to 5-FU via enhancing UMPS expression. The SNORD3A–UMPS axis may serve as a potential biomarker and therapeutic target to improve the efficacy of 5-FU-based chemotherapy for breast cancer patients.Keywords
Funding Information
- National Natural Science Foundation of China (81872197, 81672616, 81302291)
This publication has 39 references indexed in Scilit:
- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypesBreast Cancer Research and Treatment, 2013
- Posttranscriptional Gene Regulation by Long Noncoding RNAJournal of Molecular Biology, 2013
- Long Noncoding RNAs: Cellular Address Codes in Development and DiseaseCell, 2013
- Epigenetic Regulation by Long Noncoding RNAsScience, 2012
- Molecular Mechanisms of Long Noncoding RNAsMolecular Cell, 2011
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisNature, 2010
- MEIS and PBX homeobox proteins in ovarian cancerEuropean Journal of Cancer, 2007
- Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesisJournal of Bone and Joint Surgery, 2007
- Variance in the Expression of 5-Fluorouracil Pathway Genes in Colorectal CancerClinical Cancer Research, 2005
- 5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 2003